Biomarker Context: When Higher Tirzepatide Doses May Be Indicated Clinical biomarkers such as fasting glucose, HbA1c, insulin resistance markers, and lipid profiles help providers evaluate whether a patient's metabolic state warrants progression to 25 mg
The exact BUD is on the pharmacy label
The data from the Patient Health Questionnaire-9 (PHQ-9), a standard measure for depressive symptoms, supports this: At the study's start, both groups had very low average depression scores (2.7 for tirzepatide and 2.6 for placebo), indicating minimal to no symptoms
You should consult your provider if: You are currently experiencing severe side effects on your current schedule
Peptides work differently
Current guidelines recommend discontinuing GLP-1 medications before conception and using alternative treatments like insulin during pregnancy